Science Explorer Back to mapMap
Discussion
Researcher · Istituto Tumori Bari · Italy

Maria Carmela Vegliante

Maria Carmela Vegliante publishes mostly in Pathology and Forensic Medicine, Molecular Biology and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Single-cell and spatial transcriptomics.

ORCID 0000-0002-3165-1768 OpenAlex
World rank
#1,097,975
of 7,710,434 ranked researchers
Rank in Italy
#34,696
of 242,206
Works
75
Citations
1.4k
Citations per work
18.7
h-index
17
i10-index 21Top 33% in Pathology and Forensic Medicine
Maria Carmela Vegliante

What does Maria Carmela Vegliante research?

Maria Carmela Vegliante's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (19%), Immunology and Microbiology (6%).

Health Sciences: 35 works · 46.2% of their workMedicine: 35 works · 46.2% of their workPathology and Forensic Medicine: 15 works · 20.3% of their workGenetics: 7 works · 9.8% of their workOncology: 7 works · 9.8% of their workHematology: 5 works · 6.3% of their workEverything else: 22 works · 29.3% of their workLife Sciences: 18 works · 24.5% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 18.9% of their workMolecular Biology: 14 works · 18.9% of their workImmunology and Microbiology: 4 works · 5.6% of their workImmunology: 4 works · 5.6% of their workTHEIR WORKMaria CarmelaVegliante75works
Life Sciences24%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3546.2%
  2. Everything else2229.3%
    1. Biochemistry, Genetics and Molecular Biology1418.9%
    2. Immunology and Microbiology45.6%
  1. 1Pathology and Forensic Medicine20% of their works
  2. 2Molecular Biology19% of their works
  3. 3Oncology10% of their works
  4. 4Genetics10% of their works
  5. 5Hematology6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Maria Carmela Vegliante's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Chronic Lymphocytic Leukemia, Genomic Aberrations, Gene Expression and Single-Cell.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab402 topics
  2. Lymphoma342 topics
  3. Classification291 topic
  4. Molecular Profiling291 topic
  5. Chronic Lymphocytic Leukemia111 topic
  6. Genomic Aberrations111 topic
  7. Gene Expression102 topics
  8. Single-Cell61 topic
  9. Transcriptomics61 topic
  10. CAR T Cells51 topic
  11. Chimeric Antigen Receptor51 topic
  12. NK Cell Recognition51 topic
  13. Natural Killer Cells51 topic
  14. Data Analysis41 topic
  15. Microarray41 topic
  16. DNA Methylation31 topic
  17. Histone Modification31 topic
  18. Proteasome31 topic
  19. Ubiquitin31 topic

Where does Maria Carmela Vegliante work?

Maria Carmela Vegliante's main affiliation in the publication record is Istituto Tumori Bari, Italy.

How many publications and citations does Maria Carmela Vegliante have?

OpenAlex counts 75 works and 1,405 citations for Maria Carmela Vegliante, an h-index of 17, ranking #1,097,975 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Maria Carmela Vegliante. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.